Context Therapeutics Inc. (CNTX) financial statements and ratios from SEC XBRL: revenue $3.38M (TTM), net margin -1069.2%, revenue growth 5.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.38M |
| Net Margin | -1069.2% |
| Revenue Growth (YoY) | 5.6% |
| EPS Growth (YoY) | -17.4% |
| FCF Growth (YoY) | 81.4% |
| Price / Book | 1.43 |
| Price / Sales | 23.88 |
| FCF Yield | -107.6% |
| Altman Z-Score | 0.61 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CNTX overview · CNTX earnings · CNTX KPIs · CNTX investor relations · CNTX ownership · CNTX peers · CNTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.